Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06882798 · ClinicalTrials.gov registry record · NA
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
A NA study of Depressive Symptoms and Suicide Ideation, sponsored by Bradley Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06882798: Recruiting NA study of Depressive Symptoms and Suicide Ideation, sponsored by Bradley Hospital.
NCT06882798 is a NA study of Depressive Symptoms and Suicide Ideation that is actively recruiting participants, run by Bradley Hospital. The registered enrollment target is 150 participants, below the 259-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06882798, a NA study of Depressive Symptoms and Suicide Ideation, is actively recruiting participants, sponsored by Bradley Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test a model of providing treatment to Latinx/Hispanic youth, who experience suicidal thoughts and behavior, and their caregivers. An affirmative and culturally relevant treatment will be provided to all youth and half of the families will be assigned to the additional support of a community health worker (CHW). Youth symptoms and family engagement to treatment will be followed for nine months. The potential benefit of adding the CHW intervention will be assessed.
Primary Outcome
Suicidal ideation measured using the Suicide Ideation Questionnaire-Junior (SIQ-JR), a self-report instrument of 15 items that measures severity of suicidal ideation as a continuous variable with established normative, reliability, and validity data for clinical and non-clinical adolescent samples. The minimum score is 0 and the maximum 90. A higher score represents increased severity and frequency of suicidal thoughts.
Conditions Studied
Interventions
- BEHAVIORAL Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB)
- BEHAVIORAL SCBT-SB + CHW
Study Locations (1)
Rhode Island
- Bradley Hasbro Children's Research Center - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-03-28 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT06882798 shows while recruiting
NCT06882798 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 259-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (42% lower).
The record links to 3 conditions, with Depressive Symptoms appearing as the primary indexed condition, and to 2 interventions - of which Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB) is the first listed.
NCT06882798 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06882798 about?
NCT06882798 is a clinical study titled "A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior". This study will test a model of providing treatment to Latinx/Hispanic youth, who experience suicidal thoughts and behavior, and their caregivers. An affirmative and culturally relevant treatment will be provided to all youth and half of the families will be assigned to the additional support of a c...
What is the current status of trial NCT06882798?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-03-28. Estimated completion is 2027-01.
What conditions does trial NCT06882798 study?
This clinical trial studies the following conditions: Depressive Symptoms, Suicide Ideation, Suicidal Behaviors.
What interventions are being tested in trial NCT06882798?
The interventions under investigation include: Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB) (BEHAVIORAL), SCBT-SB + CHW (BEHAVIORAL).
Who is sponsoring clinical trial NCT06882798?
This trial is sponsored by Bradley Hospital, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06882798 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06882798's enrollment target sits among peer trials
150 18th of 60 higher than 41 of 60 other Depressive Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Mood and Thought Process Study
RECRUITING · NA
-
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
RECRUITING · NA
-
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
RECRUITING · NA
-
Family Spirit Strengths
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI